Acceleron Pharma Overview

Acceleron Pharma Selling, General & Admin

Selling, General & Admin expenses for XLRN.

Quarterly SG&A Expenses

$45.11M

↑ 114.39% YoY

As of Sep 30, 2021

Annual SG&A Expenses (TTM)

$137.85M

↑ 81.76% YoY

Trailing 12 months ending Sep 30, 2021

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin